Search

Search Constraints

You searched for: Author/Creator Patsouris, Anne

Search Results

1. A pharmacokinetic evaluation of alpelisib for the treatment of HR+, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer. (1st February 2021)

2. Benefits versus risk profile of buparlisib for the treatment of breast cancer. Issue 7 (3rd July 2019)

3. Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis. (July 2021)

4. Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database. (February 2022)

5. Contemporary outcomes of metastatic breast cancer among 22, 000 women from the multicentre ESME cohort 2008–2016. (April 2020)

7. Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort. (June 2022)

9. Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy. (May 2017)

10. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. (August 2020)